ABTI 0.02 Alterola Biotech, Inc.
| Range: | 0.0012-0.022 | Vol Avg: | 11398 | Last Div: | 0 | Changes: | 0.01 |
| Beta: | 1.53 | Cap: | 0.01B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Wed May 05 2010 | Empoloyees: | |||
| CUSIP: | 02152V103 | CIK: | 0001442999 | ISIN: | US02152V1035 | Country: | GB |
| CEO: | Mr. David John Hitchcock O.B.E. | Website: | https://alterola-abti.com | ||||
Alterola Biotech, Inc., a pharmaceutical company, engages in the development of cannabinoid and cannabinoid-like molecules. It focuses on the development of regulated human and animal health pharmaceuticals and regulated food products; production of active pharmaceutical ingredients and food-grade ingredients; and formulation and drug delivery for improved bioavailability, solubility, and stability. The company is based in Birkenhead, the United Kingdom.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow